Get notified when MAIA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MAIA MAIA Biotechnology, Inc. 8-K

MAIA shareholders re-elect directors, ratify auditor at 2026 annual meeting

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

  • medium

    Director Louie Ngar Yee re-elected despite 34.6% withhold votes (8,796,832 withheld vs 16,658,677 for), suggesting shareholder concern though nominee secured majority support.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Director Steven Chaouki re-elected with 98.6% support (25,109,811 for vs 345,698 withheld), reflecting strong shareholder confidence.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Grant Thornton LLP ratified as auditor with 99.4% approval (37,278,294 for vs 210,408 against), a routine outcome.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade MAIA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify